institutional
SN
NASDAQ · SNY
Sanofi
Healthcare · Drug Manufacturers - General
$44.82
Down-$0.02 (-0.04%)
Updated Aug 30, 2026, 9:38 AM
SID Score
7.2/10
Composite research score
Smart Money
54/100
Neutral
- Market cap
- 119.04B
- P/E ratio
- 11.2
- Dividend yield
- 4.94%
- 52-week range
- $40.89 – $52.68
- Volume
- 1.36M
- Avg. volume
- 2.95M
Price performance
SNY price history
1M range · 20 trading sessions · Daily adjusted prices
SNY closed at $44.82 after 20 trading sessions, up 4.35% for the selected period.
- Last close
- $44.82
- Period change
- +4.35%
- Period low
- $42.68
- Period high
- $46.02
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 28, 2026 | $44.93 | $44.96 | $44.65 | $44.82 | 1.36M |
| Aug 27, 2026 | $44.86 | $45.08 | $44.72 | $44.84 | 2.29M |
| Aug 26, 2026 | $46.01 | $46.04 | $45.39 | $45.42 | 1.63M |
| Aug 25, 2026 | $45.73 | $46.05 | $45.57 | $46.02 | 1.24M |
| Aug 24, 2026 | $45.49 | $45.78 | $45.32 | $45.69 | 1.72M |
| Aug 21, 2026 | $45.26 | $46.11 | $45.25 | $45.85 | 1.86M |
| Aug 20, 2026 | $45.65 | $45.74 | $45.06 | $45.15 | 2.6M |
| Aug 19, 2026 | $45.42 | $46.02 | $45.42 | $45.83 | 2.74M |
| Aug 18, 2026 | $45.10 | $45.22 | $44.735 | $44.97 | 3.17M |
| Aug 17, 2026 | $44.00 | $44.42 | $43.82 | $44.41 | 1.93M |
| Aug 14, 2026 | $43.51 | $43.80 | $43.235 | $43.72 | 2.72M |
| Aug 13, 2026 | $43.93 | $44.10 | $43.73 | $43.78 | 2.21M |
| Aug 12, 2026 | $43.49 | $43.78 | $43.34 | $43.71 | 2.93M |
| Aug 11, 2026 | $43.62 | $43.90 | $43.43 | $43.56 | 2.84M |
| Aug 10, 2026 | $43.53 | $43.705 | $43.32 | $43.48 | 3.36M |
| Aug 7, 2026 | $43.57 | $43.865 | $43.34 | $43.46 | 2.77M |
| Aug 6, 2026 | $43.30 | $43.51 | $42.76 | $42.89 | 4.15M |
| Aug 5, 2026 | $43.02 | $43.19 | $42.74 | $42.78 | 2.47M |
| Aug 4, 2026 | $42.77 | $42.90 | $42.54 | $42.68 | 2.28M |
| Aug 3, 2026 | $43.50 | $43.81 | $42.68 | $42.95 | 2.6M |
Latest SNY news
The latest Smart Investors Daily articles mentioning SNY.
Stock researchCompany · Financials
Loading stock research…

